Prof. Mubarak Al Mansour

Adult Oncology

Oncology | 26 years of experience | Speaks Arabic, English

Areas of Expertise:

  • GU Tumors
  • Lymphoma
  • +more

Biography

Prof. Mubarak Al-Mansour is senior medical oncologist at King’s College Hospital London in Jeddah, known for his exceptional expertise and compassionate approach to patient care. With over 16 years of experience in oncology, Prof. Al-Mansour specializes in lymphoma and GU tumors. He obtained his medical degree from King Abdulaziz University in Jeddah, followed by residency in internal medicine , Medical Oncology Fellowship, and Lymphoma Fellowship from British Columbia Cancer Agency in Canada. Prof. Al Mansour got the Canadian and American Boards in internal medicine , and canadian and American boards in Medical Oncology from the University of British Columbia.

Prof. Al-Mansour has contributed to numerous research studies in his field. He demonstrated to be a competent oncologist with an outstanding clinical judgement based on up-to-date knowledge in medical oncology. He has an analytical mind and showed a great ability and concise focused approached in the diagnosis and management of his patients.

In addition to his clinical work, Prof. Al-Mansour is an active professor in Internal Medicine / Oncology at King Saud Bin Abdulaziz University for Health Sciences in Jeddah. He also participated in several committees at King Abdulaziz Medical City, National Guard Health Affairs-WR

Education & Training

  • Lymphoma Fellowship – British Columbia Cancer Agency, Canada (2008-2009)
  • American Board in Medical Oncology, University of British Columbia (2008)
  • Canadian Board in Medical Oncology, University of British Columbia (2008)
  • Canadian Board in Internal Medicine (FRCPS), University of British Columbia (2007)
  • Medical Oncology – British Columbia Cancer Agency, Canada (2006-2007)
  • American Board in Internal Medicine (ABIM), University of British Columbia (2006)
  • Internal Medicine Residency – University of British Columbia (2003 – 2006)

Licenses & Certifications

  • Master Medical Education – King Saud bin Abdulaziz for Health Sciences (2012-2014)

Books & Publications

Al-Mansour, M. (2023) Evaluation of Problem-Based Learning in College of Medicine: An Indicator of Quality Education in a Hybrid Curriculum
Al-Mansour, M. (2023) The Outcomes of Diffuse Large B-cell Lymphoma Patients with Synchronous and Early Central Nervous System Involvement: A Single-Center Experience
Al-Mansour, M. (2023) Course Evaluations Over the Years at College of Medicine; King Saud Bin Abdul Aziz University Jeddah
Al-Mansour, M. (2022) Outcomes of high‑dose methotrexate for CNS prophylaxis in diffuse large B‑cell lymphoma with an intermediate or high CNS‑International Prognostic
Al-Mansour, M. (2022) Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study
Al-Mansour, M. (2022) Treatment Landscape of Relapsed/Refractory Mantle Cell Lymphoma: An Updated Review
Al-Mansour, M. (2022) Combination of palbociclib with adjuvant endocrine therapy for treatment of hormone receptor-positive and human epidermal growth factor receptor -negative metastatic breast cancer: An experience at two cancer centers in Saudi Arabia
Al-Mansour, M. (2022) The Risk of Developing Lymphoma among Autoimmune Thyroid Disorder Patients: A Cross-Section Study
Al-Mansour, M. (2021) PET/CT Imaging of Lymphoma Outside the Western World
Al-Mansour, M. (2021) “”Medical Students’ Perception of the Educational Environment at College of Medicine: A Prospective Study with a Review of Literature
Al-Mansour, M. (2021) Breast Implant-associated Anaplastic Large Cell Lymphoma
Al-Mansour, M. (2021) Energy and caloric restriction, and fasting and cancer: a narrative review
Al-Mansour, M. (2020) Efficacy and safety of second-generation CAR T-cell therapy in diffuse large B-cell lymphoma
Al-Mansour, M. (2020) Factors influencing patients’ preferences for their treating physician
Al-Mansour, M. (2020) Transformation of Grade I Follicular Lymphoma to Anaplastic Large Cell Lymphoma CD30+ ALK1- with Complete Response to Brentuximab Vedotin and

Professional Affiliations

  • Saudi Oncology Society
  • Scientific Committee of Saudi Lymphoma Group (SLG)
  • GU Tumors
  • Lymphoma

Slot Unavailable!

The requested doctor’s slot is not available for appointment. Please try again later.

Enquire Now